HRSA Seeks Additional Delay of CMP Rule
The 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMP) rule may be a delayed a fifth time. On March 27, 2018, HRSA sent to the White House Office of…
Fighting to Preserve the Benefits of the 340B Program
The 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMP) rule may be a delayed a fifth time. On March 27, 2018, HRSA sent to the White House Office of…
The Senate Committee on Health, Education, Labor and Pensions (HELP), which has Senate jurisdiction over the 340B program, will hold a hearing titled “Perspectives on the 340B Drug Discount Program”…
On March 1, 2018, Sen. Chuck Grassley (R-Iowa) introduced legislation that would require new federal government reporting by hospitals regarding their 340B purchases and revenue under the program. The “Ensuring…